Unity Biotechnology, Inc. Lease Obligation Incurred
Unity Biotechnology, Inc. reported Lease Obligation Incurred of $243.00 thousand for the 12-month period ending 2017-12-31, per its 10-K filed 2020-03-11.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:CapitalLeaseObligationsIncurred · last filed 2020-03-11
- Unity Biotechnology, Inc. lease obligation incurred for the quarter ending 2017-12-31 was $0.00.
- Unity Biotechnology, Inc. lease obligation incurred for the quarter ending 2017-09-30 was $147.00K.
- Unity Biotechnology, Inc. lease obligation incurred for fiscal 2017 was $243.00K.
| Period end | Lease Obligation Incurred 3 month | Lease Obligation Incurred 6 month | Lease Obligation Incurred 9 month | Lease Obligation Incurred 12 month |
|---|---|---|---|---|
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-11 | $147.00K derived: sum of 2 quarters · filed 2020-03-11 | $243.00K 10-K · filed 2020-03-11 | |
| 2017-09-30 | $147.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-07 | $243.00K 10-Q · filed 2018-11-07 | ||
| 2017-06-30 | $96.00K 10-Q · filed 2018-08-09 |